128 related articles for article (PubMed ID: 1686352)
21. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
Trentin L; Ambrosetti A; Zambello R; Agostini C; Masciarelli M; Vinante F; Chilosi M; Pizzolo G; Cetto G; Semenzato G
Leuk Res; 1987; 11(9):843-7. PubMed ID: 3499539
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic effects of human alpha interferon against human renal cancer cell line (KU-2).
Marumo K
Keio J Med; 1982 Jul; 31(1-2):7-20. PubMed ID: 7166928
[No Abstract] [Full Text] [Related]
23. Effect of recombinant human interferons on NK and K cell activities of gnotobiotic miniature swine.
Kim YB; Chung TJ
Prog Clin Biol Res; 1985; 181():329-32. PubMed ID: 3927308
[No Abstract] [Full Text] [Related]
24. Interferon alpha induces expression of the CD69 activation antigen in human resting NK cells, while interferon gamma and tumor necrosis factor alpha are ineffective.
Gerosa F; Scardoni M; Tommasi M; Benati C; Snelli L; Gandini G; Libonati M; Tridente G; Carra G
Int J Cancer; 1991 May; 48(3):473-5. PubMed ID: 1904052
[No Abstract] [Full Text] [Related]
25. Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study.
Uchiyama T; Sato N; Narita M; Yamahira A; Iwabuchi M; Furukawa T; Sone H; Takahashi M
Hematol Oncol; 2013 Sep; 31(3):156-63. PubMed ID: 23108877
[TBL] [Abstract][Full Text] [Related]
26. Interferon-alpha acts at the preoptic hypothalamus to reduce natural killer cytotoxicity in rats.
Take S; Uchimura D; Kanemitsu Y; Katafuchi T; Hori T
Am J Physiol; 1995 Jun; 268(6 Pt 2):R1406-10. PubMed ID: 7611516
[TBL] [Abstract][Full Text] [Related]
27. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
28. Modulation of natural killer and antibody-dependent cellular cytotoxicity by interferon and interleukin-2 in chronic myeloid leukemia patients in remission.
Dabholkar M; Tatake R; Amin K; Advani S; Gangal S
Oncology; 1989; 46(2):123-7. PubMed ID: 2785254
[TBL] [Abstract][Full Text] [Related]
29. Interferon therapy for lymphoproliferative disorders.
Roth MS; Bunn PA; Foon KA
Cancer Treat Res; 1988; 38():231-52. PubMed ID: 2484433
[No Abstract] [Full Text] [Related]
30. [Alpha interferon treatment in hairy cell leukemia].
Hagberg H
Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
[TBL] [Abstract][Full Text] [Related]
31. Alpha-interferon activates the natural killer system in patients with hairy cell leukemia.
Semenzato G; Pizzolo G; Agostini C; Ambrosetti A; Zambello R; Trentin L; Luca M; Masciarelli M; Chilosi M; Vinante F
Blood; 1986 Jul; 68(1):293-6. PubMed ID: 3719101
[TBL] [Abstract][Full Text] [Related]
32. Induction of DNA double-strand breaks in Chinese hamster V79 cells by 2-chlorodeoxyadenosine.
Tanabe K; Hiraoka W; Kuwabara M; Sato F; Matsuda A; Ueda T
Chem Biol Interact; 1989; 71(2-3):167-75. PubMed ID: 2574637
[TBL] [Abstract][Full Text] [Related]
33. Interaction of 2-chlorodeoxyadenosine in combination either with interferons or recombinant human tumor necrosis factor alpha on myeloid progenitor cells in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 1996; 44(4):259-64. PubMed ID: 9017167
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
[TBL] [Abstract][Full Text] [Related]
35. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon.
Fuggetta MP; Graziani G; Aquino A; D'Atri S; Bonmassar E
Int J Immunopharmacol; 1988; 10(6):687-94. PubMed ID: 3198305
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the natural killer cell response to interferon-alpha by biogenic amines.
Hellstrand K; Kylefjord H; Asea A; Hermodsson S
J Interferon Res; 1992 Jun; 12(3):199-206. PubMed ID: 1640122
[TBL] [Abstract][Full Text] [Related]
37. 2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA).
Gruber J; Geisen F; Sgonc R; Egle A; Villunger A; Boeck G; Konwalinka G; Greil R
Stem Cells; 1996 May; 14(3):351-62. PubMed ID: 8724701
[TBL] [Abstract][Full Text] [Related]
38. Natural-killer cell activity and cytogenetic response in chronic myelogenous leukemia treated with alpha-interferon.
Meseri A; Delwail V; Mahon FX; Pelletier D; Guilhot F; Brizard A; Gombert J; Tanzer J; Goube de Laforest P
Br J Haematol; 1991 Aug; 78(4):585-6. PubMed ID: 1911358
[No Abstract] [Full Text] [Related]
39. Influence of interferon alfa-2c on the kinetics of spontaneous cell-mediated cytotoxicity in urothelial carcinoma in vivo and in vitro.
Grups JW; Stock T; Frohmüller HG
Urol Res; 1988; 16(6):399-402. PubMed ID: 3232274
[TBL] [Abstract][Full Text] [Related]
40. Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
Carson DA; Piro LD; Wasson DB; Carrera CJ; Beutler E
Adv Exp Med Biol; 1989; 253A():427-31. PubMed ID: 2576181
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
